http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14671866

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 387
issn 1744-6872
issueIdentifier 5
pageRange 383-387
publicationName Pharmacogenetics and Genomics
startingPage 383
bibliographicCitation Magdelaine-Beuzelin C, Vermeire S, Goodall M, Baert F, Noman M, Assche GV, Ohresser M, Degenne D, Dugoujon JM, Jefferis R, Rutgeerts P, Lefranc MP, Watier H. IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab. Pharmacogenet Genomics. 2009 May;19(5):383–7. doi: 10.1097/fpc.0b013e32832a06bf. PMID: 19319024.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_368cb2c707fca9862c9fe1dfc371f8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da663e5753b199afd30dbbea039bae70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ec02e5029a0dba6f184591d700385d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46d4acc4a9d236c326ab0c69e316b040
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4261e13f3d79ea3fc04b19b520551a0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe33825d431377d7f84641d0fdc0a9ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63f93a51b871c3200f5f409c1ed53535
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_282b76cebd09e16bb8ab321e33b3f76a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3271b53b5f81430017d9d0c80729f46
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e68b85bf05eee01717b1965286a8f3ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cd6758bc91b008dc0846b4dea0f3638
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3947420cce483009fb90faea4f4b3bd2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_700a9e508d7f5567f2c0c95110f5a7a8
date 200905
identifier https://doi.org/10.1097/fpc.0b013e32832a06bf
https://pubmed.ncbi.nlm.nih.gov/19319024
isPartOf https://portal.issn.org/resource/ISSN/1744-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32413
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab
discusses http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0011134
http://id.nlm.nih.gov/mesh/M0376295
http://id.nlm.nih.gov/mesh/M0011102
http://id.nlm.nih.gov/mesh/M0282056
http://id.nlm.nih.gov/mesh/M0001333
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000917Q000235
http://id.nlm.nih.gov/mesh/D000911Q000276
http://id.nlm.nih.gov/mesh/D007143Q000235
http://id.nlm.nih.gov/mesh/D007074Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D003424Q000235
http://id.nlm.nih.gov/mesh/D000069285
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D015331
http://id.nlm.nih.gov/mesh/D005787
http://id.nlm.nih.gov/mesh/D000893Q000276
http://id.nlm.nih.gov/mesh/D003424Q000188
http://id.nlm.nih.gov/mesh/D003424Q000276
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005838
http://id.nlm.nih.gov/mesh/D003424Q000097
http://id.nlm.nih.gov/mesh/D000893Q000627
http://id.nlm.nih.gov/mesh/D016022
http://id.nlm.nih.gov/mesh/D000911Q000378
http://id.nlm.nih.gov/mesh/D008958
http://id.nlm.nih.gov/mesh/D007126Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b704e0181eb8cd5f159c423f9a99f152
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5531bd923baf81a265e1654f93b7486d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d71c9f3e694c282683103afaf8f20ee9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7365

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3500

Total number of triples: 61.